88 results
Page 3 of 5
8-K
EX-99.1
hd4dz
3 Feb 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
h6wxcd
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
EX-99.1
hyz6g0
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
EX-99.1
r0g3iqdm27 dsdpr
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
7sft1wzr
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
EX-1.1
9eb7a4zk41vc2qx tj
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
424B5
sfkdh2xtp
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
bq4avhg7 6n8
15 Oct 19
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
td94q57c
7 Aug 19
Other Events
9:07am
8-K
EX-99.2
1yw04dqo9a nu185
7 Aug 19
Other Events
9:07am
8-K
EX-99.1
0qya4ksv6 wrhrxrmg
29 Jul 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
ths9d4uyxwed
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
EX-99.1
qsqo qurmmo
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm